Velocity Global

OCTOBER 29, 2020

M&A activity dropped during the first two quarters of 2020 after COVID-19 created economic conditions not seen since the Great Depression. As the business world adjusts to the new normal, executives regained confidence in their companies’ outlook and the global economy. Non-financial corporations in the U.S.

Payroll 52

Payroll Regulations Government Company Focus 52

Globalization Partners

NOVEMBER 14, 2022

Macron’s broader goal is to achieve 100 French unicorns by 2030, including 25 green unicorns (companies focused on creating technology that will reduce human impact on the environment). French tech companies raised EUR 11.6 This was an increase of 115 percent against 2020. billion in funds in 2021. How G-P can help.

Government 98

Government Administrative Research Cybersecurity 98

NoonDalton

SEPTEMBER 20, 2021

In 2020, everyone was talking about finding the best way to make remote teams work. While people are feeling safe enough to start gathering in person again, it doesn’t seem likely that companies will be able to revert back to the “old” ways quite so quickly. No two companies are created equal.

Reduced Overhead 98

Reduced Overhead Right-Sizing Outsourcing BPO 98

Velocity Global

DECEMBER 23, 2020

The global economy was thrown into disarray in 2020, exposing critical supply chain vulnerabilities and causing businesses to rethink strategies. According to a recent Accenture report, 94% of Fortune 1000 companies said the pandemic led to supply chain disruptions, while 75% said COVID-19 negatively affects their businesses.

Payroll 52

Payroll Manufacturing Flexibility Operational Costs 52

IBM Services

FEBRUARY 16, 2023

The first AI-designed drug candidate to enter clinical trials was reported by Exscientia in early 2020. Since then, companies such as Insilico Medicine, Evotec and Schrödinger have announced phase I trials. Bills and regulations will increase the adoption and application of AI AI underpins the trends mentioned above.

Pharmaceuticals 40

Pharmaceuticals Reduced Costs Research Manufacturing 40